Edwards Settles Patent Dispute with Medtronic
- Share via
From Bloomberg News
Edwards Lifesciences Corp. said it agreed to settle a patent dispute with Medtronic Inc. and Medtronic Vascular Inc. over grafts used to treat various aneurysms.
Irvine-based Edwards said that in exchange for a payment of $37.5 million to Edwards and Australia-based Endogad Research Party Ltd., Medtronic had been granted nonexclusive licenses to the patents involved in the litigation and related patents.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
